LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis
USA - NASDAQ:LMAT - US5255582018 - Common Stock
86.82 USD
+1.22 (+1.43%)
86.82 USD
0 (0%)
Overall LMAT gets a fundamental rating of 7 out of 10. We evaluated LMAT against 189 industry peers in the Health Care Equipment & Supplies industry. LMAT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LMAT has a correct valuation and a medium growth rate. This makes LMAT very considerable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year LMAT was profitable.
In the past year LMAT had a positive cash flow from operations.
Each year in the past 5 years LMAT has been profitable.
In the past 5 years LMAT always reported a positive cash flow from operatings.
1.2 Ratios
LMAT's Return On Assets of 8.16% is amongst the best of the industry. LMAT outperforms 91.01% of its industry peers.
LMAT has a Return On Equity of 12.99%. This is amongst the best in the industry. LMAT outperforms 89.42% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.70%, LMAT belongs to the top of the industry, outperforming 84.13% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LMAT is in line with the industry average of 9.12%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROIC | 7.7% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
LMAT has a Profit Margin of 20.08%. This is amongst the best in the industry. LMAT outperforms 93.65% of its industry peers.
LMAT's Profit Margin has improved in the last couple of years.
LMAT has a Operating Margin of 23.34%. This is amongst the best in the industry. LMAT outperforms 93.65% of its industry peers.
LMAT's Operating Margin has improved in the last couple of years.
LMAT has a better Gross Margin (69.11%) than 76.72% of its industry peers.
LMAT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LMAT is destroying value.
LMAT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, LMAT has more shares outstanding
LMAT has a worse debt/assets ratio than last year.
2.2 Solvency
LMAT has an Altman-Z score of 7.35. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of LMAT (7.35) is better than 86.77% of its industry peers.
LMAT has a debt to FCF ratio of 3.21. This is a good value and a sign of high solvency as LMAT would need 3.21 years to pay back of all of its debts.
LMAT's Debt to FCF ratio of 3.21 is amongst the best of the industry. LMAT outperforms 85.19% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that LMAT is not too dependend on debt financing.
LMAT has a Debt to Equity ratio of 0.46. This is comparable to the rest of the industry: LMAT outperforms 44.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Altman-Z | 7.35 |
ROIC/WACC0.9
WACC8.55%
2.3 Liquidity
A Current Ratio of 13.96 indicates that LMAT has no problem at all paying its short term obligations.
LMAT's Current ratio of 13.96 is amongst the best of the industry. LMAT outperforms 98.41% of its industry peers.
LMAT has a Quick Ratio of 11.74. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
LMAT's Quick ratio of 11.74 is amongst the best of the industry. LMAT outperforms 95.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 |
3. Growth
3.1 Past
LMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.67%, which is quite good.
LMAT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.13% yearly.
LMAT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.63%.
The Revenue has been growing by 13.41% on average over the past years. This is quite good.
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
Revenue 1Y (TTM)13.63%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.37%
3.2 Future
LMAT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.76% yearly.
Based on estimates for the next years, LMAT will show a quite strong growth in Revenue. The Revenue will grow by 9.67% on average per year.
EPS Next Y19.93%
EPS Next 2Y14.3%
EPS Next 3Y12.64%
EPS Next 5Y9.76%
Revenue Next Year13.86%
Revenue Next 2Y11.2%
Revenue Next 3Y10.46%
Revenue Next 5Y9.67%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 39.64, LMAT can be considered very expensive at the moment.
69.84% of the companies in the same industry are more expensive than LMAT, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LMAT to the average of the S&P500 Index (25.83), we can say LMAT is valued expensively.
LMAT is valuated quite expensively with a Price/Forward Earnings ratio of 34.26.
Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than the industry average as 71.96% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 32.68. LMAT is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.64 | ||
| Fwd PE | 34.26 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LMAT is valued a bit cheaper than the industry average as 73.02% of the companies are valued more expensively.
76.72% of the companies in the same industry are more expensive than LMAT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.57 | ||
| EV/EBITDA | 23.04 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LMAT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of LMAT may justify a higher PE ratio.
A more expensive valuation may be justified as LMAT's earnings are expected to grow with 12.64% in the coming years.
PEG (NY)1.99
PEG (5Y)2.31
EPS Next 2Y14.3%
EPS Next 3Y12.64%
5. Dividend
5.1 Amount
With a yearly dividend of 0.93%, LMAT is not a good candidate for dividend investing.
LMAT's Dividend Yield is rather good when compared to the industry average which is at 1.92. LMAT pays more dividend than 92.06% of the companies in the same industry.
With a Dividend Yield of 0.93, LMAT pays less dividend than the S&P500 average, which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.93% |
5.2 History
The dividend of LMAT is nicely growing with an annual growth rate of 13.60%!
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
34.45% of the earnings are spent on dividend by LMAT. This is a low number and sustainable payout ratio.
The dividend of LMAT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP34.45%
EPS Next 2Y14.3%
EPS Next 3Y12.64%
86.82
+1.22 (+1.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.25%
Inst Owner Change-5.26%
Ins Owners7.8%
Ins Owner Change-9.35%
Market Cap1.97B
Revenue(TTM)219.86M
Net Income(TTM)47.12M
Analysts78.75
Price Target106.72 (22.92%)
Short Float %5.87%
Short Ratio7.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.93% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP34.45%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.86%
Min EPS beat(2)-5.52%
Max EPS beat(2)3.81%
EPS beat(4)2
Avg EPS beat(4)1.56%
Min EPS beat(4)-5.52%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)4.62%
EPS beat(12)8
Avg EPS beat(12)3.08%
EPS beat(16)8
Avg EPS beat(16)-1.76%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.79%
Max Revenue beat(2)1.83%
Revenue beat(4)3
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.31%
Revenue beat(12)6
Avg Revenue beat(12)-0.07%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)-0.15%
PT rev (3m)0.12%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)5.23%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)5.92%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)2.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.64 | ||
| Fwd PE | 34.26 | ||
| P/S | 8.38 | ||
| P/FCF | 37.57 | ||
| P/OCF | 33.45 | ||
| P/B | 5.42 | ||
| P/tB | 7.46 | ||
| EV/EBITDA | 23.04 |
EPS(TTM)2.19
EY2.52%
EPS(NY)2.53
Fwd EY2.92%
FCF(TTM)2.31
FCFY2.66%
OCF(TTM)2.6
OCFY2.99%
SpS10.36
BVpS16.02
TBVpS11.64
PEG (NY)1.99
PEG (5Y)2.31
Graham Number28.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROCE | 10.02% | ||
| ROIC | 7.7% | ||
| ROICexc | 18.52% | ||
| ROICexgc | 32.83% | ||
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% | ||
| FCFM | 22.3% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexgc growth 3Y-0.4%
ROICexgc growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Debt/EBITDA | 2.59 | ||
| Cap/Depr | 63.73% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.57% | ||
| Profit Quality | 111.05% | ||
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 | ||
| Altman-Z | 7.35 |
F-Score5
WACC8.55%
ROIC/WACC0.9
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
EPS Next Y19.93%
EPS Next 2Y14.3%
EPS Next 3Y12.64%
EPS Next 5Y9.76%
Revenue 1Y (TTM)13.63%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.37%
Revenue Next Year13.86%
Revenue Next 2Y11.2%
Revenue Next 3Y10.46%
Revenue Next 5Y9.67%
EBIT growth 1Y20%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year43.57%
EBIT Next 3Y22.42%
EBIT Next 5YN/A
FCF growth 1Y176.09%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y129.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%
LEMAITRE VASCULAR INC / LMAT FAQ
What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a fundamental rating of 7 / 10 to LMAT.
Can you provide the valuation status for LEMAITRE VASCULAR INC?
ChartMill assigns a valuation rating of 4 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.
How profitable is LEMAITRE VASCULAR INC (LMAT) stock?
LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 8 / 10.
What is the valuation of LEMAITRE VASCULAR INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LEMAITRE VASCULAR INC (LMAT) is 39.64 and the Price/Book (PB) ratio is 5.42.
What is the expected EPS growth for LEMAITRE VASCULAR INC (LMAT) stock?
The Earnings per Share (EPS) of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 19.93% in the next year.